We are dedicated to developing therapies to meet high unmet medical needs.
ANG-3777 and ANG-3070 are investigational products and are not currently approved for use by the FDA. ANG-3777 is currently being studied in ongoing clinical trials. Clinical trials study a test or a treatment given to people and help to determine safety.
All of Angion’s current clinical trials can be found on clinicaltrials.gov, including a list of sites that are recruiting patients.
If you wish to learn more about enrolling in the Phase 2 trial evaluating the safety and efficacy of ANG-3777 in preventing acute kidney injury after cardiac surgical procedures, click here.
If you wish to learn more about enrolling in the Phase 3 trial studying the safety and efficacy of ANG-3777 in reducing the severity of delayed graft function in patients at high risk after receiving a kidney transplant from a deceased donor, click here.